Dr. Nicholas Vogelzang Discusses Radium-223 In Prostate Cancer

Dr. Nicholas Vogelzang Discusses Radium-223 in Prostate Cancer

Dr. Vogelzang Reviews Radium-223 in Metastatic Prostate Cancer

Targeted Oncology

ASCO 2013 - Nicholas Vogelzang, MD, discusses Xofigo (radium Ra 223 dichloride)

Dr. Nicholas Vogelzang Discusses PSMA ADC in Prostate Cancer

Targeted Oncology

Nicholas Vogelzang, MD, provides thoughts on the role of radium 223 in management of aMPC

Dr. Nicholas Vogelzang Discusses Latest Advances in Prostate Cancer

Encore - Morning Medical Update - Prostate Cancer 2nd Opinion

The University of Kansas Health System

Dr. George on the Use of Radium-223 in Prostate Cancer

Dr. Vogelzang Discusses the Addition of Chemotherapy to ADT in Men With Prostate Cancer

Dr. Oliver Sartor Discusses Radium-223 in Early Prostate Cancer

Dr. George Discusses Radium-223 for Patients With mCRPC Part I

Dr. Nicholas Vogelzang Discusses Sequencing Abiraterone and Enzalutamide

Dr. George Discusses Radium-223 for Patients With mCRPC Part II

New data on Radium 223 presented at ASCO

MDedge: news and insights for busy physicians

Radium-223 in Bone-Metastatic Castration-Resistant Prostate Cancer

Nicholas J. Vogelzang, MD, FASCO, FACP, discusses resistance and advanced prostate cancer

Dr. Dreicer on Challenges of Radium-223 in Prostate Cancer

Dr. Daniel George on the Incorporation of Radium-223 in Advanced Prostate Cancer

Radium-223 and Metastatic Prostate Cancer

Dr. Dreicer on the Optimal Use of Radium-223 in Prostate Cancer